Neuroleptic Medications

Overview

4.6 out of 5 (18 Reviews)

Credits

1.00

Post Assessment Questions

6

Start Date

1 Jan 2021

Last Review Date

21 Feb 2024

Expiration Date

31 Dec 2023

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Neuroleptics, also known as antipsychotic medications, are used for the treatment and management of symptoms associated with various psychiatric disorders. Neuroleptic medications are categorized into 2 classes—first-generation or "typical" antipsychotics and second-generation or "atypical" antipsychotics. First-generation antipsychotics were initially developed in the 1950s primarily for the treatment of psychosis, such as schizophrenia. In addition to psychotic illnesses, first-generation antipsychotics have been approved by the US Food and Drug Administration (FDA) for treating and managing acute mania, agitation, bipolar disorder, Tourette syndrome, and hyperactivity. Furthermore, second-generation antipsychotics have also been FDA-approved to treat and manage psychosis and treatment-resistant schizophrenia, bipolar disorder, schizoaffective disorder, agitation, and irritability or agitation.

Notably, beyond their FDA-approved uses, both first- and second-generation antipsychotics are used in various neuropsychiatric conditions, which are currently considered off-label. These conditions include attention-deficit hyperactivity disorder, behavioral disturbances in dementia, geriatric agitation, depression, eating disorders, personality disorders, insomnia, generalized anxiety disorder, obsessive-compulsive disorder, posttraumatic stress disorder, and substance use and dependence disorders. For many of these conditions, the evidence is inconclusive, and clinicians should use their judgment when considering the prescription of neuroleptics. Neuroleptic medications inhibit dopamine receptors in the nervous system. This activity examines the indications and contraindications of neuroleptics, emphasizing the importance of the interprofessional healthcare team in ensuring safer prescription practices.


Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the appropriate indications for neuroleptic medications in treating various psychiatric disorders, including schizophrenia, bipolar disorder, and acute agitation.

  • Screen patients for potential contraindications or risk factors before initiating neuroleptic treatment, including cardiac conditions, metabolic disorders, and substance use disorders.

  • Apply appropriate strategies to manage and mitigate common adverse effects of neuroleptic medications, including metabolic syndrome, extrapyramidal symptoms, and sedation.

  • Collaborate with other healthcare professionals, including psychiatrists, pharmacists, and nurses, to ensure comprehensive and coordinated care for patients receiving neuroleptic medications.

Disclosures

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they or their immediate family may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CUSOM for resolution, to ensure fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

CUSOM will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for authors, editors, planners, peer reviewers, and/or relevant staff is provided with this activity.

Continuing Education Accreditation Information

 

 

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. CUSOM designates this enduring material for a maximum of 1.00 AOA Category 1 B Credits and will report CME credits commensurate with the extent of the physician's participation in the activity.

Cancellation Policy: Cancellations must be received in writing and a money back guarantee is provided if not completely satisfied.

  • StatPearls and CUSOM reserve the right to cancel any course due to unforeseen circumstances. StatPearls and CUSOM will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and CUSOM are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and CUSOM adheres to AOA Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and Campbell that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

This course is intended for osteopathic physicians who wish to earn AOA CME credit. Take this version of the course to ensure you receive appropriate credit.

 

 
 

Reviews

NICHOLAS N. on 8/23/2022

ABIODUN A. on 8/29/2022

RODOLFO L. on 9/24/2022

Rayne R. on 11/22/2022

David G. on 11/30/2022

Nancy G. on 1/5/2023

Dr.NIRMALA M. on 1/24/2023

Latoya R. on 1/29/2023

JOSE P. on 2/8/2023

P m. on 3/16/2023

jonathan s. on 5/3/2023

Mary Y. on 7/20/2023

Sendil K. on 7/31/2023

Pamela C. on 8/7/2023

Dmitriy P. on 12/1/2023

Margaret D. on 1/18/2024

Jibril Y. on 2/22/2024

Alison D. on 4/24/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$39 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user